Abstract
Background
The objective of this study is to develop and validate a machine learning (ML) prediction model for the assessment of laparoscopic total mesorectal excision (LaTME) surgery difficulty, as well as to identify independent risk factors that influence surgical difficulty. Establishing a nomogram aims to assist clinical practitioners in formulating more effective surgical plans before the procedure.
Methods
This study included 186 patients with rectal cancer who underwent LaTME from January 2018 to December 2020. They were divided into a training cohort (n = 131) versus a validation cohort (n = 55). The difficulty of LaTME was defined based on Escal’s et al. scoring criteria with modifications. We utilized Lasso regression to screen the preoperative clinical characteristic variables and intraoperative information most relevant to surgical difficulty for the development and validation of four ML models: logistic regression (LR), support vector machine (SVM), random forest (RF), and decision tree (DT). The performance of the model was assessed based on the area under the receiver operating characteristic curve(AUC), sensitivity, specificity, and accuracy. Logistic regression-based column-line plots were created to visualize the predictive model. Consistency statistics (C-statistic) and calibration curves were used to discriminate and calibrate the nomogram, respectively.
Results
In the validation cohort, all four ML models demonstrate good performance: SVM AUC = 0.987, RF AUC = 0.953, LR AUC = 0.950, and DT AUC = 0.904. To enhance visual evaluation, a logistic regression-based nomogram has been established. Predictive factors included in the nomogram are body mass index (BMI), distance between the tumor to the dentate line ≤ 10 cm, radiodensity of visceral adipose tissue (VAT), area of subcutaneous adipose tissue (SAT), tumor diameter >3 cm, and comorbid hypertension.
Conclusion
In this study, four ML models based on intraoperative and preoperative risk factors and a nomogram based on logistic regression may be of help to surgeons in evaluating the surgical difficulty before operation and adopting appropriate responses and surgical protocols.
Supplementary Information
The online version contains supplementary material available at 10.1186/s12957-024-03389-3.
Keywords: Rectal cancer, Surgical difficulty, Machine learning, Nomogram, Prediction model
Background
Colorectal cancer is the third most common cancer in the world and the second leading cause of cancer deaths, with rectal cancer (RC) accounting for one-third of the total [1, 2]. Despite the availability of various therapeutic options, surgical resection is still the primary treatment for early- to mid-stage and even partially advanced rectal cancer (RC) [3]. Laparoscopic total mesorectal excision (LaTME) is recognized as the surgical technique of choice for the treatment of rectal cancer, with a pathologic safety profile and overall survival rate no less than that of open surgery [4]. However, due to the complexity and high level of difficulty of the procedure, intraoperative conversion to open surgery and complications are relatively common. Although these conditions do not indicate surgical failure, they significantly affect the prognosis [4, 5]. Therefore, preoperative surgical evaluation is particularly important.
Multiple studies have been conducted to confirm the consequences of obesity on surgical difficulties, with most focusing on BMI [6–8]. While BMI is an estimation of generalized obesity, it does not accurately reflect the relationship with surgical difficulties. Therefore, the assessment of abdominal fat is deemed more significant compared to BMI [9]. The use of computed tomography (CT) to measure the area and mean radiodensity of abdominal visceral adipose tissue and subcutaneous adipose tissue has been validated in the majority of studies [10, 11], ensuring its reliability. The inclusion of the area and radiodensity of visceral adipose tissue and subcutaneous adipose tissue in this study allows for a more comprehensive assessment of obesity concerning surgical difficulty.
Machine learning (ML), a burgeoning form of artificial intelligence (AI), is increasingly being applied in healthcare data analysis. ML excels in connecting multiple variables and accurately predicting outcomes. Consequently, several ML prediction models are currently being adopted for disease diagnosis, prognosis prediction, and clinical decision-making [12, 13], and the objective of this study was to utilize machine learning with nomograms to establish a preoperative prediction model for the surgical difficulty of laparoscopic rectal cancer surgery, to identify preoperative independent predictors of surgical difficulty that consequence the difficulty of the surgery, and consequently, to help medical surgeons to develop personalized surgical options for their patients preoperatively.
Materials and methods
Patients
The Ethics Committee of the Second Affiliated Hospital of Soochow University approved our retrospective study. It conforms to the 1964 Helsinki Declaration of the World Medical Association and its subsequent revisions. This study included 186 patients who underwent laparoscopic total mesorectal excision (LaTME) from January 2018 to December 2020 in the Department of Gastrointestinal Surgery of the Second Affiliated Hospital of Soochow University.
The inclusion criteria were:
(1)Preoperative pathological examination that confirmed the diagnosis of rectal cancer; (2) complete computed tomography (CT) scan and clinical data within two weeks before surgery; (3) preoperative plan for laparoscopic total mesorectal excision (LaTME).
The exclusion criteria were :
(1) Emergency surgery; (2) open surgery; (3) preoperative adjuvant treatment such as radiotherapy or chemotherapy; (4) clinical stage 4 or huge tumor that was inoperable. Clinicopathologic parameters were retrospectively collected from the medical record database. The Clavien-Dindo classification [14] was utilized to classify postoperative short-term complications.
Data collection
For patients included in the study, the following parameters are retrospectively collected from our hospital’s electronic medical record system: (1) Basic patient characteristics: age, gender, BMI, American Society of Anesthesiologists (ASA) score, and comorbidities (hypertension, diabetes). (2) Laboratory results: albumin, hemoglobin, triglycerides, total cholesterol, C-reactive protein, and Systemic Inflammatory Grade (SIG) [15]within two weeks before surgery. (3) Intraoperative data: surgical time and the need for conversion. (4) Postoperative data: pathological results, hospitalization time, and postoperative complications classified according to the Clavien-Dindo classification.
CT abdominal adipose tissue measurements
Visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) parameters are calculated and averaged using Slice-O-Matic software (version 5.0; TomoVision) at the level of the fourth and fifth lumbar vertebral interspaces by selecting two consecutive CT cross-Sect. (5 mm). Cross-sectional areas are delineated based on anatomical knowledge and tissue-specific Hounsfield unit (HU) ranges of -150 to -50 HU for VAT and − 190 to -30 HU for SAT [16]. For two CT scans of the same patient, regions of interest are outlined separately by two individuals trained in software usage and then averaged (Supplementary Fig. S1). If substantial differences exist between the two outlines, a third person reviews and verifies the measurements.
Surgical difficulty criteria
Based on the criteria established by Escal et al. [17] and in combination with the research by Y. Seki et al. [9], which demonstrates that patients with a visceral fat area/body surface area (VFA/BSA) ≥ 85 cm2/m2 present greater surgical challenges, refinements have been made to formulate the scoring criteria. The scoring system encompasses five factors related to surgical difficulty, each factor being assigned a weighting based on clinical experience. Scores range from 0 to 10 points and are divided into two categories: a cumulative score below 3 points indicates non-difficult surgery, while a score of 3 points or higher signifies surgical difficulty (Table 1). The five variables associated with surgical difficulty show significant differences between the surgical-difficulty group and the non-surgical difficulty group (P < 0.05) (Supplementary Table S1).
Table 1.
Points | |
---|---|
Duration of surgery >300 min | 3 |
Conversion to open procedure | 3 |
Postoperative hospital stay >14 days | 2 |
VAT/BAS>85 cm2/m2 | 1 |
Morbidity (grade II and III) | 1 |
(VFA /BSA) visceral fat area/body surface area
Establishment of machine learning models
We utilized R software (version 4.3.1) to set a fixed random seed of grouping and randomly divided all patients into two groups according to 7:3, training cohort (n = 131) and validation cohort (n = 55). To simplify the machine learning model and enhance its generalization capability, 10 cross-validated LASSO regressions are employed to reduce variable dimensionality. The filtering criterion is based on the lambda. min variable, with the most optimal model fit observed at lambda.min = 0.007424. Fifteen out of the twenty-one variables with the highest predictive power for surgical difficulties are selected (Fig. 1). It has also been demonstrated that age [18], and ASA [19] have an consequence on the performance of the procedure, and therefore they were included as model predictor variables.
In this study, a total of four machine learning models were selected to predict the degree of surgical difficulty: support vector machine (SVC), random forest (RF), logistic regression (LR), and decision tree (DT). In the training cohort, we individually parameterized all models to tune to prevent overfitting or underfitting, and the same hyperparameters were used in the validation cohort to assess the predictive ability of the models. In the training cohort, we adjusted the parameters of all models to prevent overfitting or underfitting and used the same hyperparameters in the validation cohort to evaluate the predictive ability of the models.
Statistical analysis
Statistical analyses are conducted using the statistical R software (version 4.3.1) package. Continuous data that adhere to a normal distribution are presented as mean and standard deviation (SD), while non-normally distributed continuous data are displayed as median and interquartile range (IQR). Categorical data are represented as frequency and percentage (%). T-tests are utilized for the comparison of continuous variables, and χ2 tests are employed for the comparison of categorical variables. Predictive nomograms are developed. The variables selected for inclusion in the nomogram are determined through the backward stepwise method of Akaike’s information criterion, and factors with a multifactor logistic regression P < 0.05 are included. Calibration curves are created to evaluate the calibration of the nomogram. Furthermore, Harrell’s C-index is calculated, and bootstrap validation of the nomogram is performed (using 1000 bootstrap weight samples) to compute the C-index of relative calibration. Decision curve analysis (DCA) is also conducted. Statistical significance is defined as P < 0.05.
Results
Patient characteristics
A total of 186 patients were included in the final analysis, including 112 males (60.22%) and 74 females (39.78%). The median age was 66 years, the median BMI was 23.35 kg/m2, 76 had comorbid hypertension, and 21 had diabetes mellitus.101 had tumors > 3 cm in diameter, 88 had tumors to the dentate line ≥ 10 cm, the median visceral adipose tissue radiodensity was − 94.08 U, the median subcutaneous adipose tissue radiodensity was − 97.34 U, and the median subcutaneous adipose tissue area median was 127.55 cm2. 147 had preoperative serum albumin ≥ 35 g/L. There were no significant differences in clinical characteristics and CT parameters between the training and the validation cohorts (P > 0.05) (Table 2).
Table 2.
Variable | Total (n = 186) | Training cohort (n = 131) | Validation cohort (n = 55) | P |
---|---|---|---|---|
Baseline characteristics of the patients | ||||
Age(mean [SD], year) | 66 ± 11 | 66.57 ± 11 | 64 ± 10 | 0.322 |
BMI (median [IQR], kg/m²) | 23.35 (21.63–25.48) | 23.44 (21.50–25.59) | 23.18 (21.97–25.20) | 0.847 |
Gender, n (%) | 0.772 | |||
Female | 74 (39.78) | 53 (40.46) | 21 (38.18) | |
Male | 112 (60.22) | 78 (59.54) | 34 (61.82) | |
ASA, n (%) | 0.726 | |||
1 | 22 (11.83) | 17 (12.98) | 5 (9.09) | |
2 | 114 (61.29) | 80 (61.07) | 34 (61.82) | |
3 | 50 (26.88) | 34 (25.95) | 16 (29.09) | |
Hypertension, n (%) | 0.863 | |||
No | 110 (59.14) | 78 (59.54) | 32 (58.18) | |
Yes | 76 (40.86) | 53 (40.46) | 23 (41.82) | |
Diabetes, n (%) | 0.157 | |||
No | 165 (88.71) | 119 (90.84) | 46 (83.64) | |
Yes | 21 (11.29) | 12 (9.16) | 9 (16.36) | |
CT measurement parameters | ||||
SAT area(mean [SD], cm2) | 127.55 ± 55.04 | 128.57 ± 59.40 | 125.13 ± 43.29 | 0.699 |
SAT Radiodensity(mean [SD], U) | -97.34 ± 9.03 | -96.95 ± 8.73 | -98.27 ± 7.10 | 0.367 |
VAT Radiodensity( mean [SD], U) | -94.08 ± 8.36 | -94.18 ± 8.57 | -93.83 ± 7.89 | 0.793 |
Distance between tumor and the dentate line, n (%) | 0.053 | |||
< 10cm | 98 (52.69) | 63 (48.09) | 35 (63.64) | |
≥ 10 cm | 88 (47.31) | 68 (51.91) | 20 (36.36) | |
Tumor diameter, n (%) | 0.355 | |||
≤ 3 cm | 85 (45.7) | 57 (43.51) | 28 (50.91) | |
>3 cm | 101 (54.3) | 74 (56.49) | 27 (49.09) | |
Pathological stage | ||||
Pathological T stage, n (%) | 0.982 | |||
T1 | 132 (70.97) | 93 (70.99) | 39 (70.91) | |
T2 | 43 (23.12) | 30 (22.90) | 13 (23.64) | |
T3 | 11 (5.91) | 8 (6.11) | 3 (5.45) | |
Pathological N stage, n (%) | 0.195 | |||
N0 | 112 (60.22) | 75 (57.25) | 37 (67.27) | |
N1 | 39 (20.97) | 27 (20.61) | 12 (21.82) | |
N2 | 35 (18.82) | 29 (22.14) | 6 (10.91) | |
Nerve invasion, n (%) | 0.396 | |||
No | 146 (78.49) | 105 (80.15) | 41 (74.55) | |
Yes | 40 (21.51) | 26 (19.85) | 14 (25.45) | |
Vascular tumor emboli, n (%) | 0.661 | |||
No | 152 (81.72) | 106 (80.92) | 46 (83.64) | |
Yes | 34 (18.28) | 25 (19.08) | 9 (16.36) | |
Blood Laboratory indicators | ||||
Preoperative total cholesterol (median [IQR]) | 4.63 (4.24–5.20) | 4.59 (4.17–5.11) | 4.65 (4.30–5.23) | 0.381 |
Preoperative triglyceride(median [IQR]) | 1.18 (0.95–1.45) | 1.23 (1.01–1.46) | 1.09 (0.71–1.38) | 0.021 |
Preoperative C reactive protein count(median [IQR]) | 5.20 (4.70–5.70) | 5.10 (4.70–5.70) | 5.50 (4.90–5.70) | 0.058 |
Preoperative serum albumin, n (%) | 0.854 | |||
<35 g/L | 39 (20.97) | 27 (20.61) | 12 (21.82) | |
≥ 35 g/L | 147 (79.03) | 104 (79.39) | 43 (78.18) | |
Preoperative hemoglobin (mean [SD]) | 129.78 ± 17.67 | 128.90 ± 16.78 | 131.87 ± 19.63 | 0.296 |
SIG, n (%) | 0.22 | |||
0 | 121 (65.05) | 87 (66.41) | 34 (61.82) | |
1 | 46 (24.73) | 31 (23.66) | 15 (27.27) | |
2 | 13 (6.99) | 7 (5.34) | 6 (10.91) | |
3 | 6 (3.23) | 6 (4.58) | 0 (0.00) |
BMI body mass index; ASA American Society of Anesthesiologists; SAT subcutaneous fatty tissue; VAT visceral adipose tissue; SIG Systemic Inflammatory Grade
Construction of machine learning models
Four machine learning models - Support Vector Machine (SVC), Random Forest (RF), Logistic Regression (LR), and Decision Tree (DT) - were selected for this study. The optimal hyperparameters were calculated by repeating the cross-validation five times considering the accuracy and AUC. Subsequently, the optimal hyperparameters were derived by manual tuning. We also obtained the following parameters: sensitivity, specificity, precision, recall, and F1 (Table 3). Using AUC as the evaluation criterion, the optimal performance in the training cohort: SVM AUC = 0.995 (0.988-1.000), the other models are LR AUC = 0.994 (0.987-1.000), DT AUC = 0.970 (0.943–0.996) and RF AUC = 0.963 (0.935–0.999). The best performance in the validation cohort: SVM AUC = 0.987 (0.962-1.000) and the other models are RF AUC = 0.953 (0.901-1.000), LR AUC = 0.950 (0.889-1.000) and DT AUC = 0.904 (0.805-1.000)( Fig. 2). The De-Long test is employed to compare the predictive efficacy of the four machine learning models, the results indicated no significant differences among the models (P > 0.05), all of which demonstrated superior predictive performance (Supplementary Table S2).
Table 3.
Training Cohort | Validation Cohort | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Model | AUC | Accuracy | Sensitivity | Specificity | Recall | F1 Score | AUC | Accuracy | Sensitivity | Specificity | Recall | F1 Score | ||
SVM | 0.995 | 0.954 | 0.936 | 1 | 0.936 | 0.96 | 0.987 | 0.855 | 0.8 | 1 | 0.8 | 0.889 | ||
DT | 0.97 | 0.9466 | 0.919 | 0.957 | 0.919 | 0.907 | 0.904 | 0.836 | 0.933 | 0.8 | 0.933 | 0.757 | ||
RF | 0.963 | 0.9 | 0.946 | 0.883 | 0.946 | 0.843 | 0.953 | 0.873 | 0.867 | 0.875 | 0.867 | 0.788 | ||
LR | 0.994 | 0.969 | 0.971 | 0.967 | 0.919 | 0.944 | 0.95 | 0.855 | 0.733 | 0.9 | 0.733 | 0.733 |
Results of univariate and multivariate logistic regression analysis
After univariate and multivariate logistic regression, it was identified that BMI (OR:1.52, 95% CI: 1.10–2.11), SAT area (OR:1.02, 95% CI: 1.01–1.04), VAT radiodensity (OR:1.34, 95% CI: 1.16–1.56), the distance between the tumor and the dentate line < 10 cm (OR:0.03, 95% CI: 0.01–0.21), tumor diameter > 3 cm (OR:0.14, 95% CI: 0.03–0.82), and comorbid hypertension (OR:0.19, 95% CI: 0.04–0.83) were independent risk factors for surgical difficulties( Table 4).
Table 4.
Variables | Univariate | Multivariate | ||
---|---|---|---|---|
OR (95%CI) | P | OR (95%CI) | P | |
Age | 1.02 (0.98–1.05) | 0.307 | ||
Gender | ||||
Female | Reference | |||
Male | 1.37 (0.62–3.01) | 0.437 | ||
BMI | 1.12 (1.01–1.26) | 0.047 | 1.52 (1.10–2.11) | 0.011 |
ASA | ||||
2 | Reference | |||
3 | 0.34 (0.12–0.97) | 0.044 | 0.64 (0.10–4.27) | 0.642 |
1 | 0.82 (0.26–2.56) | 0.730 | 1.86 (0.28–12.36) | 0.52 |
Hypertension | ||||
Yes | Reference | |||
No | 0.14 (0.06–0.32) | < 0.001 | 0.20 (0.05–0.87) | 0.032 |
Preoperative hemoglobin | 1.00 (0.98–1.02) | 0.886 | ||
Preoperative serum albumin | ||||
≥ 35 g/L | Reference | |||
<35 g/L | 5.75 (2.33–14.21) | < 0.001 | 5.10 (0.91–28.60) | 0.064 |
Preoperative total cholesterol | 0.87 (0.54–1.40) | 0.565 | ||
Preoperative triglyceride | 1.61 (0.89–2.88) | 0.112 | ||
Preoperative C -reactive protein count | 1.00 (0.99–1.02) | 0.759 | ||
SAT area | 1.01 (1.01–1.01) | 0.045 | 1.02 (1.01–1.04) | 0.013 |
SAT Radiodensity | 0.96 (0.91–1.01) | 0.098 | ||
VAT Radiodensity | 1.12 (1.06–1.18) | < 0.001 | 1.34 (1.16–1.56) | < 0.001 |
Distance between tumor and the dentate line | ||||
<10 cm | Reference | |||
≥ 10 cm | 0.13 (0.05–0.32) | < 0.001 | 0.03 (0.01–0.21) | < 0.001 |
SIG | ||||
3 | Reference | |||
0 | 2.50 (0.28–22.40) | 0.413 | ||
1 | 1.20 (0.12–12.27) | 0.878 | ||
2 | 0.83 (0.04–16.99) | 0.906 | ||
Tumor diameter | ||||
>3 cm | Reference | |||
≤ 3 cm | 0.10 (0.03–0.30) | < 0.001 | 0.14 (0.03–0.82) | 0.029 |
Diabetes | ||||
No | Reference | |||
Yes | 1.30 (0.37–4.62) | 0.682 |
BMI body mass index; ASA American Society of Anesthesiologists; SAT subcutaneous fatty tissue; VAT visceral adipose tissue; SIG Systemic Inflammatory Grade
Development and validation of nomogram
To make the evaluation more intuitive, we created nomogram based on logistic regression, as logistic regression makes it easier to interpret nomogram. In the nomogram model, variable selection was based on a backward stepwise screening using the Akaike information criterion requiring P < 0.05: BMI, tumor distance from the dentate line, tumor diameter, VAT radiodensity, SAT area, and comorbid hypertension were included in the variables used to construct the nomogram(Fig. 3). The C- indices are all greater than 0.9, indicating that the predictive ability of the model has a high degree of confidence(Fig. 4a). Furthermore, the Decision Curve Analysis (DCA) showed significantly better net benefit in the predictive model(Fig. 4b). The calibration curves for this nomogram demonstrated favorable concordance (Bootstrap = 1000 repetitions, mean absolute error (training cohort) = 0.042, mean absolute error (validation cohort) = 0.039) (Fig. 5), and we also performed the Hosmer and Lemeshow tests, which indicated that both the training cohort and validation cohort indicated a good fit (training cohort P = 0.853; validation cohort P = 0.400).
Discussion
In this study, four machine learning models were developed and validated for predicting the difficulty of LaTME. Based on the comparison of the ML models, all four ML models showed high performance, with the AUC of the SVM standing out in the training and validation groups, but not significantly different from the other models. Meanwhile, to further visualize the assessment of surgical difficulty, we also constructed a logistic regression-based nomogram, according to which clinical surgeons can use the nomogram to calculate the risk probability of surgical difficulty, to make adequate preoperative and intraoperative preparations.
LaTME is perhaps the most challenging type of surgery in colorectal surgery. Appropriate pelvic debridement and total mesorectal excision (TME) are essential to prevent local recurrence [20]. Previous studies have focused on the consequence of pelvic factors and rectal mesenteric fat area on the surgical outcome of lower and middle rectal cancer [21, 22], the consequence of a large vertical pelvic depth, a small pelvis, a short transverse meridian, a large sacrococcygeal curvature and a high rectal mesenteric fat area on the difficulty of the procedure was also determined [17, 23, 24], and these factors are particularly significant for men [25]. However, the relationship between quantitative pelvic measurements and surgical difficulty is uncertain, and some studies have even found no association between pelvic measurements and surgical difficulty [26]. Our study demonstrated that abdominal adipose tissue is an independent consequence of the difficulty of laparoscopic rectal cancer surgery. The assessment of abdominal visceral fat is important because it can result in the intraoperative separation of the visceral layer from the abdominal fascia, the exposure of the rectal vessels, and the smoke when applying the ultrasonic knife [27]. Therefore, we included VAT in the surgical difficulty assessment score to further refine the preoperative assessment of surgical difficulty. We found that there was a significant difference in the radiodensity of visceral adipose tissue between the two groups of patients, and according to one study, the radiodensity of fat was also associated with overall survival and mortality in colorectal cancer, and it was also demonstrated that this phenomenon may be due to: inflammation, browning of the adipose tissue, and edematous disorders [16, 28], and therefore, we hypothesized that the consequence of the radiodensity of fat on surgery may also be related to this, which, of course, requires further exploration and discussion.
BMI is considered to be the most common indicator describing overall obesity [29, 30], and previous studies have shown that high BMI has a significant consequence on postoperative outcomes after rectal surgery [4, 31, 32], but in recent years an “obesity paradox” has emerged [33–35]. A meta-study showed that obese patients (including class I/II/II) had a lower mortality rate within 30 days than patients with normal BMI, but a higher mortality rate after 30 days than patients with normal BMI [33], which reflects the limitations of BMI and the value of our study.
Our study also indicated that hypertensive patients are more difficult to operate, and a study has proved that the prevalence of hypertension is higher in patients with abdominal visceral obesity [36], therefore, hypertensive patients may still be due to abdominal visceral obesity, of course, we didn’t do more research and have no direct evidence to prove this, so I believe that we will have a report on this in the future.
Escal et al. [17]and other studies [37] included blood loss in the scoring criteria, and we considered that in some surgeries, which are interfered with by factors such as abdominal lavage, the measurement of blood loss may not be completely accurate, which may result in the grouping of surgical difficulty in some patients. Therefore, to formulate the prediction model more objectively, to make the model more persuasive, and to facilitate the generalization of the model, we did not include blood loss in the scoring factors, and we do not deny that intraoperative blood loss may reflect the difficulty of surgery to a certain extent. In the future, we will also include standardized measurements of blood loss in the scoring criteria.
In addition, robotic total rectal mesentery resection is now widely used, and several studies have shown that robotic total rectal mesentery resection is non-inferior to laparoscopic total rectal mesentery resection in terms of both short-term outcomes of postoperative complications and overall survival [25, 38–41], and even superior to laparoscopic total rectal mesentery resection. The rigidity of laparoscopic instruments and the limitation of operating space may affect specimen quality, and the robotic device may overcome the above disadvantages of laparoscopic instruments, resulting in better specimen quality and reduced local recurrence [42]. Interestingly, VFA with rectal mesenteric adipose tissue did not have significant clinical significance for the postoperative pathological safety of robotic total rectal mesentery resection [43, 44], which needs to be validated by a large sample from a multicentric population.
Laparoscopic and open surgery are still the dominant procedures for the treatment of rectal cancer [45], and therefore this study remains essential. In addition to the factors we investigated that consequence in the difficulty of rectal surgery, several studies have demonstrated that a history of previous abdominal surgery, preoperative radiotherapy, surgeon’s proficiency, preoperative patient’s nutritional status, and other factors can influence the difficulty of laparoscopic surgery [46, 47]. Although various factors consequence the difficulty of surgery, we believe that the scoring criteria demonstrated by Escal et al. [17] are more objective, and we believe that more factors will be included in the scoring of surgical difficulty in the future, thus further improving the objectivity and persuasiveness of the scoring, and also providing ideas for the evaluation of other surgeries.
Of course, this study has a few limitations. First, this is a retrospective study with a small number of enrolled patients, so selection bias cannot be completely ruled out and a larger sample size from more centers is needed for further validation. Second, laboratory tests, clinicopathologic features, and abdominal CT parameters were included in this study, but since CT only measures the mean area of two planes of the abdomen and does not measure the volume of abdominal fat, errors may arise as a result; finally, we only selected some of the clinical biochemical indexes, and factors that were not included may lead to residual confounders.
Conclusions
This study developed four ML models for evaluating surgical difficulty, all of which indicated excellent efficacy, and to further visualize the evaluation, logistic regression-based nomograms are created. Both the training cohort and validation cohort confirmed the excellent performance of the models, providing clinicians with easy-to-use tools to help them make accurate surgical decisions. Of course, further validation through multi-center and large sample sizes is needed to ensure the prediction effect.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Abbreviations
- LaTME
laparoscopic total mesorectal excision
- LR
logistic regression
- SVM
support vector machine
- RF
random forest decision tree
- DT
decision tree
- BMI
body mass index
- RC
rectal cancer
- CT
computerized tomography
- ML
machine learning
- ASA
American Society of Anesthesiologists
- SAT
subcutaneous fatty tissue
- VAT
visceral adipose tissue
- VFA
/BSA visceral fat area/body surface area
- SIG
Systemic Inflammatory Grade
- HU
Hounsfield units
- AUC
Area under the receiver operating characteristic curve
- ROC
Receiver operating characteristic curve
- CI
Confidence interval
Author contributions
XL and YW conceptualized and designed the work. XL and ZZ collected all the data. XL and BZ drafted and analyzed the manuscript. CX and YW reviewed and revised the manuscript. All authors contributed to the manuscript and approved the version as submitted.
Funding
The present study was supported by State Key Laboratory of Radiation Medicine and Protection (No. GZK1202243), Suzhou Science and Technology Bureau (No.SKY2022156).
Data availability
No datasets were generated or analysed during the current study.
Declarations
Ethics approval
It complies with the World Medical Association Declaration of Helsinki in 1964 and subsequently amended versions.
Consent to participate
An informed consent form was signed.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Xiangyong Li, Zeyang Zhou and Bing Zhu authors contributed equally to this work.
Contributor Information
Yong Wu, Email: wuyong6302@163.com.
Chungen Xing, Email: xingcg@126.com.
References
- 1.Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49. doi: 10.3322/caac.21660. [DOI] [PubMed] [Google Scholar]
- 2.Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7–33. doi: 10.3322/caac.21708. [DOI] [PubMed] [Google Scholar]
- 3.Jiang WZ, Xu JM, Xing JD, Qiu HZ, Wang ZQ, Kang L, Deng HJ, Chen WP, Zhang QT, Du XH, et al. Short-term outcomes of Laparoscopy-assisted vs open surgery for patients with low rectal Cancer: the LASRE Randomized Clinical Trial. JAMA Oncol. 2022;8:1607–15. doi: 10.1001/jamaoncol.2022.4079. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Alimova I, Chernyshov S, Nagudov M, Rybakov E. Comparison of oncological and functional outcomes and quality of life after transanal or laparoscopic total mesorectal excision for rectal cancer: a systematic review and meta-analysis. Tech Coloproctol. 2021;25:901–13. doi: 10.1007/s10151-021-02420-z. [DOI] [PubMed] [Google Scholar]
- 5.Paun BC, Cassie S, MacLean AR, Dixon E, Buie WD. Postoperative complications following surgery for rectal cancer. Ann Surg. 2010;251:807–18. doi: 10.1097/SLA.0b013e3181dae4ed. [DOI] [PubMed] [Google Scholar]
- 6.Yang PF, Ang ZH, Badiani S, Berney CR, Morgan MJ. Impact of obesity on patients undergoing surgery for rectal cancer in Australia and New Zealand. Int J Colorectal Dis. 2023;38:163. doi: 10.1007/s00384-023-04447-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Poelemeijer YQM, Lijftogt N, Detering R, Fiocco M, Tollenaar R, Wouters M. Obesity as a determinant of perioperative and postoperative outcome in patients following colorectal cancer surgery: a population-based study (2009–2016) Eur J Surg Oncol. 2018;44:1849–57. doi: 10.1016/j.ejso.2018.05.027. [DOI] [PubMed] [Google Scholar]
- 8.Bell S, Kong JC, Wale R, Staples M, Oliva K, Wilkins S, Mc Murrick P, Warrier SK. The effect of increasing body mass index on laparoscopic surgery for colon and rectal cancer. Colorectal Dis. 2018;20:778–88. doi: 10.1111/codi.14107. [DOI] [PubMed] [Google Scholar]
- 9.Seki Y, Ohue M, Sekimoto M, Takiguchi S, Takemasa I, Ikeda M, Yamamoto H, Monden M. Evaluation of the technical difficulty performing laparoscopic resection of a rectosigmoid carcinoma: visceral fat reflects technical difficulty more accurately than body mass index. Surg Endosc. 2007;21:929–34. doi: 10.1007/s00464-006-9084-9. [DOI] [PubMed] [Google Scholar]
- 10.Kim JM, Chung E, Cho ES, Lee JH, Shin SJ, Lee HS, Park EJ, Baik SH, Lee KY, Kang J. Impact of subcutaneous and visceral fat adiposity in patients with colorectal cancer. Clin Nutr. 2021;40:5631–8. doi: 10.1016/j.clnu.2021.10.001. [DOI] [PubMed] [Google Scholar]
- 11.Ebadi M, Martin L, Ghosh S, Field CJ, Lehner R, Baracos VE, Mazurak VC. Subcutaneous adiposity is an independent predictor of mortality in cancer patients. Br J Cancer. 2017;117:148–55. doi: 10.1038/bjc.2017.149. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Buk Cardoso L, Cunha Parro V, Verzinhasse Peres S, Curado MP, Fernandes GA. Wunsch Filho V, Natasha Toporcov T: machine learning for predicting survival of colorectal cancer patients. Sci Rep. 2023;13:8874. doi: 10.1038/s41598-023-35649-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Feng JW, Ye J, Qi GF, Hong LZ, Wang F, Liu SY, Jiang Y. A comparative analysis of eight machine learning models for the prediction of lateral lymph node metastasis in patients with papillary thyroid carcinoma. Front Endocrinol (Lausanne) 2022;13:1004913. doi: 10.3389/fendo.2022.1004913. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibanes E, Pekolj J, Slankamenac K, Bassi C, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187–96. doi: 10.1097/SLA.0b013e3181b13ca2. [DOI] [PubMed] [Google Scholar]
- 15.Golder AM, Conlan O, McMillan DC, Mansouri D, Horgan PG, Roxburgh CS. Adverse tumour and Host Biology May explain the poorer outcomes seen in emergency presentations of Colon cancer. Ann Surg. 2023;278:e1018–25. doi: 10.1097/SLA.0000000000005872. [DOI] [PubMed] [Google Scholar]
- 16.Feliciano EMC, Winkels RM, Meyerhardt JA, Prado CM, Afman LA, Caan BJ. Abdominal adipose tissue radiodensity is associated with survival after colorectal cancer. Am J Clin Nutr. 2021;114:1917–24. doi: 10.1093/ajcn/nqab285. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Escal L, Nougaret S, Guiu B, Bertrand MM, de Forges H, Tetreau R, Thezenas S, Rouanet P. MRI-based score to predict surgical difficulty in patients with rectal cancer. Br J Surg. 2018;105:140–6. doi: 10.1002/bjs.10642. [DOI] [PubMed] [Google Scholar]
- 18.Rodriguez-Otero Luppi C, Targarona Soler EM, Balague Ponz C, Pantoja Millan JP, Turrado Rodriguez V, Pallares Segura JL, Bollo Rodriguez J, Trias Folch M. Clinical, anatomical, and Pathological Grading Score to Predict Technical Difficulty in Laparoscopic Splenectomy for non-traumatic diseases. World J Surg. 2017;41:439–48. doi: 10.1007/s00268-016-3683-y. [DOI] [PubMed] [Google Scholar]
- 19.Sun M, Xu M, Sun J. Risk factor analysis of postoperative complications in patients undergoing emergency abdominal surgery. Heliyon. 2023;9:e13971. doi: 10.1016/j.heliyon.2023.e13971. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1986;1:1479–82. doi: 10.1016/S0140-6736(86)91510-2. [DOI] [PubMed] [Google Scholar]
- 21.Martinez-Perez A, Espin E, Pucciarelli S, Ris F, DeAngelis N, EuMa RCSSG. Commentary on the role of MRI pelvimetry in predicting technical difficulty and outcomes of open and minimally invasive total mesorectal excision: a systematic review. Tech Coloproctol. 2021;25:981–2. doi: 10.1007/s10151-020-02343-1. [DOI] [PubMed] [Google Scholar]
- 22.Killeen T, Banerjee S, Vijay V, Al-Dabbagh Z, Francis D, Warren S. Magnetic resonance (MR) pelvimetry as a predictor of difficulty in laparoscopic operations for rectal cancer. Surg Endosc. 2010;24:2974–9. doi: 10.1007/s00464-010-1075-1. [DOI] [PubMed] [Google Scholar]
- 23.Zhang Q, Wei J, Chen H. Advances in pelvic imaging parameters predicting surgical difficulty in rectal cancer. World J Surg Oncol. 2023;21:64. doi: 10.1186/s12957-023-02933-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Yuan Y, Tong D, Liu M, Lu H, Shen F, Shi X. An MRI-based pelvimetry nomogram for predicting surgical difficulty of transabdominal resection in patients with middle and low rectal cancer. Front Oncol. 2022;12:882300. doi: 10.3389/fonc.2022.882300. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Aliyev V, Piozzi GN, Bulut A, Guven K, Bakir B, Saglam S, Goksel S, Asoglu O. Robotic vs. laparoscopic intersphincteric resection for low rectal cancer: a case matched study reporting a median of 7-year long-term oncological and functional outcomes. Updates Surg. 2022;74(6):1851–60. doi: 10.1007/s13304-022-01396-1. [DOI] [PubMed] [Google Scholar]
- 26.Ogiso S, Yamaguchi T, Hata H, Fukuda M, Ikai I, Yamato T, Sakai Y. Evaluation of factors affecting the difficulty of laparoscopic anterior resection for rectal cancer: narrow pelvis is not a contraindication. Surg Endos. 2011;25(6):1907–12. doi: 10.1007/s00464-010-1485-0. [DOI] [PubMed] [Google Scholar]
- 27.Yuan W, Wang X, Wang Y, Wang H, Yan C, Song G, Liu C, Li A, Yang H, Gao C, Chen J. Development and validation of a nomogram for predicting operating time in laparoscopic anterior resection of rectal cancer. J Cancer Res Ther. 2023;19:964–71. doi: 10.4103/jcrt.jcrt_2223_22. [DOI] [PubMed] [Google Scholar]
- 28.Oikawa KH, Juliani FL, Carrilho LAO, Pozzuto L, Padilha DMH, Silveira MN, Costa FO, Macedo LT, da Cunha Junior AD, Mendes MCS, Carvalheira JBC. Abdominal adiposity as a prognosis biomarker of clinical outcome in metastatic colorectal cancer. Nutrition. 2023;107:111913. doi: 10.1016/j.nut.2022.111913. [DOI] [PubMed] [Google Scholar]
- 29.Caballero B. Humans against Obesity: Who Will Win? Adv Nutr 2019, 10:S4-S9. [DOI] [PMC free article] [PubMed]
- 30.Zou Y, Pitchumoni CS. Obesity, obesities, and gastrointestinal cancers. Dis Mon. 2023;69:101592. doi: 10.1016/j.disamonth.2023.101592. [DOI] [PubMed] [Google Scholar]
- 31.Collaborative ST. Multicentre prospective cohort study of body mass index and postoperative complications following gastrointestinal surgery. Br J Surg. 2016;103:1157–72. doi: 10.1002/bjs.10203. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Chen J, Sun Y, Chi P, Sun B. MRI pelvimetry-based evaluation of surgical difficulty in laparoscopic total mesorectal excision after neoadjuvant chemoradiation for male rectal cancer. Surg Today. 2021;51:1144–51. doi: 10.1007/s00595-020-02211-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Cullinane C, Fullard A, Croghan SM, Elliott JA, Fleming CA. Effect of obesity on perioperative outcomes following gastrointestinal surgery: meta-analysis. BJS Open 2023, 7. [DOI] [PMC free article] [PubMed]
- 34.Mullen JT, Moorman DW, Davenport DL. The obesity paradox: body mass index and outcomes in patients undergoing nonbariatric general surgery. Ann Surg. 2009;250:166–72. doi: 10.1097/SLA.0b013e3181ad8935. [DOI] [PubMed] [Google Scholar]
- 35.Dindo D, Muller MK, Weber M, Clavien PA. Obesity in general elective surgery. Lancet. 2003;361:2032–5. doi: 10.1016/S0140-6736(03)13640-9. [DOI] [PubMed] [Google Scholar]
- 36.El Meouchy P, Wahoud M, Allam S, Chedid R, Karam W, Karam S. Hypertension related to obesity: Pathogenesis, characteristics and factors for control. Int J Mol Sci 2022, 23. [DOI] [PMC free article] [PubMed]
- 37.Lv J, Guan X, Wei R, Yin Y, Liu E, Zhao Z, Chen H, Liu Z, Jiang Z, Wang X. Development of artificial blood loss and duration of excision score to evaluate surgical difficulty of total laparoscopic anterior resection in rectal cancer. Front Oncol. 2023;13:1067414. doi: 10.3389/fonc.2023.1067414. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Feng Q, Yuan W, Li T, Tang B, Jia B, Zhou Y, Zhang W, Zhao R, Zhang C, Cheng L, Zhang X, Liang F, He G, Wei Y, Xu J, REAL Study Group Robotic versus laparoscopic surgery for middle and low rectal cancer (REAL): short-term outcomes of a multicentre randomised controlled trial. Lancet Gastroenterol Hepatol. 2022;7(11):991–1004. doi: 10.1016/S2468-1253(22)00248-5. [DOI] [PubMed] [Google Scholar]
- 39.Aliyev V, Piozzi GN, Huseynov E, Mustafayev TZ, Kayku V, Goksel S, Asoglu O. Robotic male and laparoscopic female sphincter-preserving total mesorectal excision of mid-low rectal cancer share similar specimen quality, complication rates and long-term oncological outcomes. J Robot Surg. 2023;17(4):1637–44. doi: 10.1007/s11701-023-01558-2. [DOI] [PubMed] [Google Scholar]
- 40.Shadmanov N, Aliyev V, Piozzi GN, Bakır B, Goksel S, Asoglu O. Perioperative and long-term oncological outcomes of robotic versus laparoscopic total mesorectal excision: a retrospective study of 672 patients. J Robot Surg. 2024;18(1):144. doi: 10.1007/s11701-024-01922-w. [DOI] [PubMed] [Google Scholar]
- 41.Aliyev V, Piozzi GN, Shadmanov N, Guven K, Bakır B, Goksel S, Asoglu O. Robotic and laparoscopic sphincter-saving resections have similar peri-operative, oncological and functional outcomes in female patients with rectal cancer. Updates Surg. [DOI] [PubMed]
- 42.Gachabayov M, Lee H, Kajmolli A, Felsenreich DM, Bergamaschi R, RESURRECT Study Group. : Impact of robotic total mesorectal excision upon pathology metrics in overweight males with low rectal cancer: a pooled analysis of 836 cases. Updates in surgery 2023,12. [DOI] [PubMed]
- 43.Felsenreich DM, Gachabayov M, Bergamaschi R, RESURRECT Study Group Does the mesorectal fat area impact the histopathology metrics of the specimen in males undergoing TME for distal rectal cancer? Updates Surg. 2023;75(3):581–8. doi: 10.1007/s13304-022-01429-9. [DOI] [PubMed] [Google Scholar]
- 44.Gachabayov M, Felsenreich DM, Bhatti S, Bergamaschi R, RESURRECT Study Group Does the visceral fat area impact the histopathology specimen metrics after total mesorectal excision for distal rectal cancer? Langenbecks Arch Surg. 2023;408(1):257. doi: 10.1007/s00423-023-02981-7. [DOI] [PubMed] [Google Scholar]
- 45.Keller DS, Berho M, Perez RO, Wexner SD, Chand M. The multidisciplinary management of rectal cancer. Nat Rev Gastroenterol Hepatol. 2020;17:414–29. doi: 10.1038/s41575-020-0275-y. [DOI] [PubMed] [Google Scholar]
- 46.Duron JJ. Postoperative intraperitoneal adhesion pathophysiology. Colorectal Dis. 2007;9(Suppl 2):14–24. doi: 10.1111/j.1463-1318.2007.01343.x. [DOI] [PubMed] [Google Scholar]
- 47.Li Q, Li D, Jiang L, Qiu P, Fu Z, Tang L, Chen W. Factors influencing Difficulty of Laparoscopic Abdominoperineal Resection for Ultra-low rectal Cancer. Surg Laparosc Endosc Percutan Tech. 2017;27:104–9. doi: 10.1097/SLE.0000000000000378. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
No datasets were generated or analysed during the current study.